<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64695</article-id><article-id pub-id-type="doi">10.7554/eLife.64695</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>A novel, ataxic mouse model of Ataxia Telangiectasia caused by a clinically relevant nonsense mutation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-215337"><name><surname>Perez</surname><given-names>Harvey</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215338"><name><surname>Abdallah</surname><given-names>May F</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215339"><name><surname>Chavira</surname><given-names>Jose I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258235"><name><surname>Norris</surname><given-names>Angelina S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215340"><name><surname>Egeland</surname><given-names>Martin T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215341"><name><surname>Vo</surname><given-names>Karen L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215343"><name><surname>Buechsenschuetz</surname><given-names>Callan L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215342"><name><surname>Sanghez</surname><given-names>Valentina</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215344"><name><surname>Kim</surname><given-names>Jeannie L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215345"><name><surname>Pind</surname><given-names>Molly</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215346"><name><surname>Nakamura</surname><given-names>Kotoka</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215347"><name><surname>Hicks</surname><given-names>Geoffrey G</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-10"/><xref ref-type="other" rid="par-11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215348"><name><surname>Gatti</surname><given-names>Richard A</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215349"><name><surname>Madrenas</surname><given-names>Joaquin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6191-3733</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215350"><name><surname>Iacovino</surname><given-names>Michelina</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-68970"><name><surname>McKinnon</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-132597"><name><surname>Mathews</surname><given-names>Paul J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1991-0798</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Neurology</institution>, <institution>The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center</institution>, <addr-line><named-content content-type="city">Torrance</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Undergraduate Studies</institution>, <institution>The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center</institution>, <addr-line><named-content content-type="city">Torrance</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Pediatrics</institution>, <institution>The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center</institution>, <addr-line><named-content content-type="city">Torrance</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Biochemistry and Medical Genetics</institution>, <institution>University of Manitoba</institution>, <addr-line><named-content content-type="city">Manitoba</named-content></addr-line>, <country>Canada</country></aff><aff id="aff5"><institution content-type="dept">Laboratory Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Biochemistry and Medical Genetics</institution>, <institution>University of Manitoba</institution>, <addr-line><named-content content-type="city">Manitoba</named-content></addr-line>, <country>Canada</country></aff><aff id="aff7"><institution content-type="dept">Department of Laboratory Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Medicine</institution>, <institution>The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center</institution>, <addr-line><named-content content-type="city">Torrance</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-11653"><name><surname>Sillitoe</surname><given-names>Roy V</given-names></name><role>Reviewing editor</role><aff><institution>Baylor College of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>pmathews@ucla.edu</email> (PM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>11</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e64695</elocation-id><history><date date-type="received"><day>07</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>29</day><month>10</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Perez et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Perez et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64695-v1.pdf"/><abstract><p>Ataxia Telangiectasia (A-T) and Ataxia with Ocular Apraxia Type 1 (AOA1) are devastating neurological disorders caused by null mutations in the genome stability genes, A-T mutated (<italic>ATM</italic>) and Aprataxin (<italic>APTX</italic>), respectively. Our mechanistic understanding and therapeutic repertoire for treating these disorders is severely lacking, in large part due to the failure of prior animal models with similar null mutations to recapitulate the characteristic loss of motor coordination (i.e., ataxia) and associated cerebellar defects. By increasing genotoxic stress through the insertion of null mutations in both the <italic>Atm</italic> (nonsense) and <italic>Aptx </italic>(knockout) genes in the same animal, we have generated a novel mouse model that for the first time develops a progressively severe ataxic phenotype associated with atrophy of the cerebellar molecular layer. We find biophysical properties of cerebellar Purkinje neurons are significantly perturbed (e.g., reduced membrane capacitance, lower action potential thresholds, etc.), while properties of synaptic inputs remain largely unchanged. These perturbations significantly alter Purkinje neuron neural activity, including a progressive reduction in spontaneous action potential firing frequency that correlates with both cerebellar atrophy and ataxia over the animal’s first year of life. Double mutant mice also exhibit a high predisposition to developing cancer (thymomas) and immune abnormalities (impaired early thymocyte development and T-cell maturation), symptoms characteristic of A-T. Lastly, by inserting a clinically relevant nonsense-type null mutation in <italic>Atm</italic>, we demonstrate that Small Molecule Read-Through (SMRT) compounds can restore ATM production, indicating their potential as a future A-T therapeutic.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R21NS108117</award-id><principal-award-recipient><name><surname>Mathews</surname><given-names>Paul J</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000861</institution-id><institution>Sparks</institution></institution-wrap></funding-source><award-id>13CAL01</award-id><principal-award-recipient><name><surname>Gatti</surname><given-names>Richard A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R33NS096044</award-id><principal-award-recipient><name><surname>Iacovino</surname><given-names>Michelina</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R21NS108117-01S1</award-id><principal-award-recipient><name><surname>Mathews</surname><given-names>Paul J</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R03NS103066</award-id><principal-award-recipient><name><surname>Mathews</surname><given-names>Paul J</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>American Lebanese and Syrian Associated Charities of St. Jude Children's Hospital</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>McKinnon</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS037956</award-id><principal-award-recipient><name><surname>McKinnon</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P01CA096832</award-id><principal-award-recipient><name><surname>McKinnon</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006108</institution-id><institution>National Center for Advancing Translational Sciences</institution></institution-wrap></funding-source><award-id>UL1TR001881</award-id><principal-award-recipient><name><surname>Mathews</surname><given-names>Paul J</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution>Manitoba Research Innovation</institution></institution-wrap></funding-source><award-id>312864</award-id><principal-award-recipient><name><surname>Hicks</surname><given-names>Geoffrey G</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution>Cancer Care Manitoba Foundation</institution></institution-wrap></funding-source><award-id>761023032</award-id><principal-award-recipient><name><surname>Hicks</surname><given-names>Geoffrey G</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All the animals were handled according to approved institutional animal care and use committee (IACUC) protocols at The Lundquist Institute (31374-03, 31773-02) and UCLA (ARC-2007-082, ARC-2013-068). The protocol was approved by the Committee on the Ethics of Animal Experiments of the Lundquist Institute (Assurance Number: D16-00213). Every effort was made to minimize pain and suffering by providing support when necessary and choosing ethical endpoints.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting source data files.</p></sec><supplementary-material><ext-link xlink:href="elife-64695-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>